// App-Quantinova.ai

4331 : Nuclear size of circulating tumor cells is associated with prognosis in metastatic, castration-resistant prostate cancer

Researchers

Presenter

  • JASMINE J. WANG

Principal Investigators

  • Yu Jen Jan

  • Jie-Fu Chen

  • Galen Cook-Wiens

  • Nu Yao

  • Gina C. Chu

  • Pin-Jung Chen

  • Yingying Yang

  • Yee Hui Yeo

  • Yi-Te Lee

  • Leland W. Chung

  • Sungyong You

  • Yazhen Zhu

  • Michael R. Freeman

  • Andre Rogatko

  • Ju Dong Yang

  • Hsian-Rong Tseng

  • Edwin M. Posadas

Medical Centers

  • Cedars Sinai Medical Center, CA.

  • Washington University, St Louis, MO

  • University of Southern California, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • Enzalutamide

  • CB-7598

  • Androgen Tear

  • L-Tyrosine

  • taxane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved